GA

Girdhar Agarwal

Active Director Director DIN 01720977
DIN 01720977 First appointment Mar 1992 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 1992
Shareholding value •••• Premium profile

About Girdhar Agarwal

Data last updated:

Girdhar Agarwal is a Director at Carminol Laboratories Pvt Ltd (since 1992). The company operates in Pharma. Carminol Laboratories Pvt Ltd reported revenue of ₹2.63 Cr (FY 2025).

DIN 01720977
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 1992
Oldest Company Age 49 yrs
Largest company Carminol Laboratories Pvt Ltd · ₹2.63 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Carminol Laboratories Pvt Ltd U85195RJ1977PTC001739
Director30 Mar 19921977₹2.63 Cr (FY 2025)Active

Board colleagues of Girdhar Agarwal

Directorship timeline

Open interactive timeline →
Carminol Laboratories Pvt Ltd
Premium access

Shareholding and investment profile for Girdhar Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girdhar Agarwal

Girdhar Agarwal currently holds 1 directorship: Carminol Laboratories Pvt Ltd (Director, since 30 Mar 1992, revenue ₹2.63 Cr (FY 2025)).

Girdhar Agarwal was first appointed on 30 Mar 1992 as Director at Carminol Laboratories Pvt Ltd.

The current boards of Girdhar Agarwal's companies include Jagdish Prasad Agarwal (Carminol Laboratories Pvt Ltd), Sushila Devi Agrawal (Carminol Laboratories Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available